COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management
Coronavirus disease 2019 (COVID-19), which is becoming a global pandemic, is caused by SARS-CoV-2 infection. In COVID-19, thrombotic events occur frequently, mainly venous thromboembolism (VTE), which is closely related to disease severity and clinical prognosis. Compared with historical controls, t...
Main Authors: | Xianghui Zhou, Zhipeng Cheng, Yu Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/12/1328 |
Similar Items
-
Advances in the Diagnosis of Venous Thromboembolism: A Literature Review
by: Harish Patel, et al.
Published: (2020-06-01) -
Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need
by: Benjamin Brenner, et al.
Published: (2022-03-01) -
Clinical epidemiology of venous thromboembolic disease: An institutional registry
by: Mohammed AlSheef, et al.
Published: (2022-07-01) -
Editorial: COVID-19 and Venous Thromboembolism
by: Yugo Yamashita
Published: (2021-12-01) -
Venous thromboembolism in viral diseases: A comprehensive literature review
by: Nasibeh Zerangian, et al.
Published: (2023-02-01)